Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Other OTC
  5. AXIM Biotechnologies, Inc.
  6. News
  7. Summary
    AXIM   US05463V1008

AXIM BIOTECHNOLOGIES, INC.

(AXIM)
SummaryChartsNewsCompanyFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AXIM BIOTECHNOLOGIES, INC.
03/14AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical ..
AQ
01/17AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for D..
AQ
01/17AXIM Biotechnologies, Inc. Files Patent on Fentanyl Neutralizing Antibody Test, Applies..
CI
01/12AXIM Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
AQ
01/11AXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
PR
2022AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic T..
GL
2022AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic T..
AQ
2022AXIM Biotechnologies, Inc. Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnos..
CI
2022AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM'..
GL
2022AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM'..
AQ
2022AXIM Biotechnologies, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Part..
GL
2022AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Part..
AQ
2022AXIM Biotechnologies, Inc. Receives Initial Order for Diagnostic Solutions as Exclusive..
CI
2022AXIM Biotechnologies selling its ophthalmic point-of-care (POC) diagnostic product port..
AQ
More most relevant news
All news about AXIM BIOTECHNOLOGIES, INC.
03/14AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical ..
AQ
01/27Axim Biotechnologies, Inc. : Entry into a Material Definitive Agreement, Creation of a Dir..
AQ
01/17AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for D..
AQ
01/17AXIM Biotechnologies, Inc. Files Patent on Fentanyl Neutralizing Antibody Test, Applies..
CI
01/12AXIM Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
AQ
01/11AXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
PR
2022AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic T..
GL
2022AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic T..
AQ
2022AXIM Biotechnologies, Inc. Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnos..
CI
2022AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM'..
GL
More news
News in other languages on AXIM BIOTECHNOLOGIES, INC.
01/17AXIM Biotechnologies, Inc. dépose un brevet sur le test d'anticorps neutralisant le fen..
2022AXIM Biotechnologies, Inc. développe un nouveau test de diagnostic ophtalmologique rapi..
2022AXIM Biotechnologies, Inc. annonce ses résultats pour le troisième trimestre et les neu..
2022AXIM Biotechnologies, Inc. reçoit une première commande de solutions de diagnostic en t..
2022Axim® Biotechnologies signe un accord exclusif de commercialisation mondiale avec Versé..
2022Achat d'initiés : Axim Biotechnologies
2022AXIM Biotechnologies, Inc. annonce ses résultats pour le deuxième trimestre et les six ..
2022AXIM Biotechnologies, Inc. Améliore ses capacités de dépistage des IgE ; répond à l'imp..
2022AXIM Biotechnologies publie une étude mettant en évidence les niveaux d'anticorps neutr..
2022AXIM Biotechnologies, Inc. achève l'optimisation du seul test de diagnostic rapide des ..
More news
Press releases
03/14AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical ..
AQ
01/27Axim Biotechnologies, Inc. : Entry into a Material Definitive Agreement, Creation of a Dir..
AQ
01/17AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for D..
AQ
01/12AXIM Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
AQ
01/11AXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
PR
More press releases
Upcoming sector events
04/27/23ALNYLAM PHARMACEUTICALS, INC. : Q1 2023 Earnings Release (Projected)
04/27/23SEAGEN INC. : Q1 2023 Earnings Release (Projected)
05/03/23IQVIA HOLDINGS INC. : Q1 2023 Earnings Release (Projected)
05/11/23MODERNA, INC. : Q1 2023 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer